MentionFox
Home › funding signals › Arkea Bio Corp.
Form D · on the record

Arkea Bio Corp. — $15M Form D filing, October 2026

Arkea Bio Corp. filed a Form D with the Securities and Exchange Commission on 2026-10-09.

Arkea Bio Corp. filed a Form D notice of an exempt securities offering with the SEC on October 9, 2026. The filing reports $15M sold. Its industry group is Other Technology. It names Frank Wooten (Executive Officer, Director), Zachariah Serber (Executive Officer), Chris Rivest (Director) (SEC Form D, October 9, 2026).

5 more Other Technology raises in Massachusetts, October 2026 ↓

Sell to companies like Arkea Bio Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Key facts

Run the free check on Arkea Bio Corp. →

Arkea Bio Corp.

New Form D on file · 2026-10-09 · the record

$15M
raise on the record
D
filing
2
investors in
MASSACHUSETTS
based
Open the record →

What the record says

FilingForm D
Filed2026-10-09
Industry groupOther Technology
Entity typeCorporation
Incorporated inDELAWARE
BasedCHARLESTOWN, MASSACHUSETTS
CIK2004801
Accession0002004801-26-000001

Pitching, partnering or investing alongside them? See who really runs and owns Arkea Bio Corp.

Watch Arkea Bio Corp.

Free to see. No signup.

Keep reading

More on the people and the money behind Arkea Bio Corp., from the filings we hold.

More raises like this

Other Technology raises by companies based in Massachusetts, filed in October 2026, largest first.

What do you want to do with Arkea Bio Corp.?

Get the full cited report on Arkea Bio Corp.

What the filing shows about Arkea Bio Corp.

  • 2 investors had already put money in when it filed.
  • The filing names 4 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Arkea Bio Corp.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

What the filing says

  • Offered: $32,999,992. Sold: $14,999,995. Left to sell: $17,999,997. (filing)
  • Investors: 2 had already invested. (filing)
  • Date of first sale: September 28, 2026. (filing)
  • Types of securities: Equity. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on Arkea Bio Corp. See pricing

Filing history · 3 filings on this registrant
Form D · 2023-12-20Form D · 2025-10-14 · $7MForm D · 2026-10-09 · $15M · this page 2023-12-20 2026-10-09

Each marker is one filing. The larger marker is the filing this page is about.

Other Technology · by week
This raise, $15M, filed week of Oct 5

Trailing twelve months. 3831 filings in Other Technology, totalled by week. The dot is this raise, $15M, on the same scale — one filing against the whole group's total, so it sits low by construction.

Want the whole picture on Arkea Bio Corp.?

What the filing shows about Arkea Bio Corp.

  • 2 investors had already put money in when it filed.
  • The filing names 4 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Arkea Bio Corp.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Arkea Bio Corp. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind Arkea Bio Corp.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov.

Follow this companyRSS

Tools for this story

Each opens in a new tab, filled in for Arkea Bio Corp.. With no account yet, you sign up free and land on the result.

Share this page

Just raised? Share it.

Arkea Bio Corp.: Raised $15M, Form D filed 2026-10-09

Cite this page

Permanent URL: https://mentionfox.com/funding/arkea-bio-corp-form-d-000001
Last updated 2026-10-20
Primary record: SEC filing 1 · SEC filing 2
Arkea Bio Corp. raised $15M — SEC Form D filing, October 2026. MentionFox, 2026-10-20. https://mentionfox.com/funding/arkea-bio-corp-form-d-000001